Chief Clinical Officer; CCO); Senior Healthcare

Key internal interfaces include the CEO, executive leadership team, healthcare asset leaders, quality and patient safety teams, clinical operations, digital health, legal and compliance, talent acquisition, and partnership teams. Key external interfaces include regulators, accreditation bodies, clinical partners, academic institutions, sports federations, professional teams, and other strategic healthcare partners.

The Chief Medical Officer (CMO) is QHC's most senior clinical executive and the single accountable owner of enterprise clinical strategy, medical governance, quality, patient and athlete safety, and clinical standards across all QHC healthcare assets. Reporting to the Chief Executive Officer, the CMO brings clinical leadership, standards-setting, assurance, and medical advisory authority under one role, ensuring clear and consistent clinical accountability while operational delivery remains with the respective healthcare businesses and functions.

The CMO ensures that clinical delivery across all QHC healthcare assets follows the QHC's clinical and wellness standards, quality expectations, and readiness requirements, reflecting international evidence-based practice and applicable Saudi regulatory requirements.

As a member of the QHC executive leadership team, the CMO translates the Kingdom's Vision 2030 and Qiddiya’s healthcare ambitions into governed, accountable practice, championing patient and athlete safety, clinical research and academic collaboration, and positioning QHC as a regionally recognized centre of clinical excellence.

The role sets enterprise clinical standards, quality expectations, and governance requirements for all QHC healthcare assets, while day-to-day operational delivery, staffing deployment, and business-unit execution remain accountable to the relevant operating leaders.

• Provide overall clinical leadership and set the enterprise clinical strategy for QHC across all current and future service lines, in alignment with the QIC and Vision 2030 healthcare transformation objectives.
• Serve as the principal clinical voice on the executive leadership team, advising the CEO / MD and the Board and Medical Advisory Committee on clinical strategy, service development, clinical risk and medical policy.
• Provide clinical and wellness input into service models and define the clinical standards, quality expectations and readiness requirements for all healthcare assets.
• Represent QHC's clinical capabilities to sports federations, professional teams, government stakeholders, regulators and strategic partners.

• Establish QHC's overarching clinical governance and quality framework, setting expectations for patient and athlete safety, clinical quality, risk and compliance across all healthcare assets.
• Provide a consistent enterprise-wide framework for clinical quality and accountability, ensuring clear standards and expectations across all healthcare assets.
• Define, monitor, and report enterprise clinical KPIs and quality dashboards for clinical partnership or assets under direct operation of QHC.
• Define clinical governance and escalation requirements, ensure appropriate review of priority quality, safety, and service issues, and provide senior clinical guidance on corrective actions, risk mitigation, and follow-up accountability.

• Set QHC's enterprise clinical excellence, safety and wellness standards across all healthcare assets, aligned with evidence-based international practice and applicable Saudi regulatory requirements
• Provide clinical and wellness guidance to all healthcare assets on service models, safety requirements and areas for clinical improvement
• Develop and continuously review clinical policies, evidence-based care pathways, treatment protocols and standard operating procedures of clinical partners and QHC operated assets aligned with international best practice.
• Promote evidence-based, person-centred models of care that integrate physical, psychological and social dimensions of health, wellbeing and performance, as relevant to the populations served.
• Set enterprise clinical requirements for documentation, information governance, patient confidentiality and related clinical compliance, in line with applicable Saudi regulatory requirements and relevant international standards.